昱星攜HCS Pharma、Molecular Devices 共探iPSC類器官篩藥技術 -環球生技月刊 | 華人第一生醫產業KOL資料庫平台 (Yuxing, together with HCS Pharma and Molecular Devices, jointly explores iPSC organoid drug screening technology)

LumiSTAR Biotechnology (LumiSTAR Biotechnology), together with partners from France and the United States - HCS Pharma and Molecular Devices, jointly held a focus symposium at the Asian Biotechnology Conference to "advance frontier research on drug screening" as the main axis, sharing how to use innovative technologies and platforms, based on in vitro organoid models, to reduce the waste of resources caused by trial and error, and shorten the development time of new drugs.